RFK Jr Eases Unapproved Peptides Access

What happened

The outlets' own sentences, most widely reported first. Hover or tap one to see who reported it.

Analysis

How it changed

1. 28 Oct

   The move comes as a growing “gray market” has sprung up around peptides, where retailers sell them labeled “for research use only,” a legal workaround that lets them claim they aren’t meant for humans.

   6 outlets · NBC News
2. 29 Oct

   "The policy does not ... establish clinical safety and effectiveness," HHS said.

   2 outlets · ABC News

Coverage 9 articles

• 29 Oct US Health Secretary RFK Jr to expand access to unapproved peptidesUS Health Secretary Robert F Kennedy Jr has announced plans to relax restrictions on six unapproved peptides through compounding pharmacies, despite warnings from health experts about their potential risks due to insufficient human clinical trials and unknown long-term side effects. The draft regulation was published in the US Federal Register and will undergo a public comment period following its official…BBC
• 29 Oct RFK Jr. to ease access to unapproved peptides, draft policy statesRobert F. Kennedy Jr., U.S. Health and Human Services Secretary, released a draft policy Wednesday allowing compounding pharmacies to prepare six unapproved peptides for individual patients despite lacking FDA approval. The policy aims to provide safer alternatives under quality control measures like ingredient traceability and safety reporting. Although the FDA's own scientists opposed this move due to insufficient…CBS News
• 29 Oct RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use themHealth Secretary Robert F. Kennedy Jr. announced a new policy allowing the widespread use of six unapproved peptide compounds, despite the FDA advising against their use due to potential risks. The Health and Human Services Department will not take enforcement action against those selling these peptides, arguing that easing access will provide patients with controlled alternatives while protecting safety through…The Independent
• 29 Oct Some wellness peptides will become widely available, HHS saysThe Health and Human Services (HHS) announced on Wednesday that it will temporarily allow compounding pharmacies to produce six wellness peptides by prescription, including BPC-157 and TB-500. These peptides have been marketed online for various health benefits like tissue repair and skin improvement, though there is no clinical evidence supporting these claims. The HHS stated that this decision aims to provide…ABC News (US)
• 29 Oct Trump administration will allow pharmacies to make popular peptidesThe Trump administration's Department of Health and Human Services plans to relax restrictions on six unproven peptides, allowing small compounding pharmacies to produce them despite lacking FDA approval. This policy change supports wellness influencers and some clinicians who promote these peptides for various health issues like ulcerative colitis and insomnia, though evidence of their safety and effectiveness is…NPR
• 28 Oct The Peptide Rush Has BegunThe U.S. Department of Health and Human Services announced on October 28 that it will not take enforcement action against licensed pharmacists who dispense six unapproved peptides to consumers. These peptides include BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500, which are short chains of amino acids injected for various health benefits, despite scientific uncertainty about their safety and efficacy. The policy…Time
• 28 Oct FDA scientists opposed Trump administration’s move to ease peptide accessFDA scientific staff members opposed a Trump administration plan pushed by Health Secretary Robert F Kennedy Jr, which aimed to ease access to unproven peptide drugs in the US wellness industry. The policy, posted online by HHS on Wednesday, would allow specialty pharmacies to sell several peptides without FDA approval, despite warnings from FDA scientists about potential safety risks. This move faces significant…The Guardian
• 28 Oct FDA scientists opposed the Trump administration's move to ease peptides accessFDA scientific staff largely opposed a Trump administration plan aimed at easing access to unproven peptide drugs, despite pushback from Health Secretary Robert F. Kennedy Jr. This policy would allow specialty pharmacies to sell peptides without the FDA's rigorous safety and effectiveness review process, which are currently considered illegal drugs. Most FDA drug staffers warned that this could undermine the…Toronto Star
• 28 Oct RFK Jr. takes shortcut to make some peptides more widely availableThe Department of Health and Human Services has temporarily allowed compounding pharmacies to manufacture six unapproved peptides without legal repercussions while the FDA formalizes new rules for their production. These peptides include BPC-157, epitalon, KPV, MOTS-c, semax, and TB-500, which are marketed as treatments for various health conditions but lack FDA approval due to insufficient safety and efficacy data…NBC News

Keep exploring

Similar coverageDangerous Peptide Fad In NSW Hospitals Similar coverageTrump Health Research Funding Control Similar coverageFDA Nominee Confirmation Hearing RecentFlavio Bolsonaro Declares Himself President-Elect RecentIsrael Election Deadlock RecentBrewers Win First World Series Title RecentSpanish Train Crash Kills Dozens RecentUK Autumn Budget 2026 RecentHegseth Fires Top Military Planner RecentJudge Alvin Hellerstein Dies At 92